Last reviewed · How we verify
BCI-838
At a glance
| Generic name | BCI-838 |
|---|---|
| Sponsor | BrainCells Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers (PHASE1)
- A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |